On the path to untreatable infections: colistin use in agriculture and the end of ‘last resort’ antibiotics

Expert Review of Anti-Infective Therapy

Volumn 14, Issue 9, 2016, Pages 785-788

  Watkins, Richard R ^a,b   Smith, Tara C ^c   Bonomo, Robert A ^d,e  

^a Northeast Ohio Medical University   (United States)

^b AKRON GENERAL MEDICAL CENTER   (United States)

^c KENT STATE UNIVERSITY   (United States)

^d LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

agriculture; antibiotic resistance; Colistin

Indexed keywords

CARBAPENEM; CEPHALOSPORIN DERIVATIVE; COLISTIMETHATE; COLISTIN; IMIPENEM; POLYMYXIN; VACCINE; ANTIINFECTIVE AGENT; COLISTINMETHANESULFONIC ACID; ESCHERICHIA COLI PROTEIN; MCR-1 PROTEIN, E COLI;

AGRICULTURE; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; DRUG USE; EDITORIAL; ENTEROBACTERIACEAE; FARM ANIMAL; HOSPITAL INFECTION; HUMAN; INFECTION; NONHUMAN; VETERINARY MEDICINE; ANALOGS AND DERIVATIVES; ANIMAL HUSBANDRY; ESCHERICHIA COLI; EUROPEAN UNION; GENETICS; MULTIDRUG RESISTANCE; PHYSIOLOGY;

AGRICULTURE; ANIMAL HUSBANDRY; ANTI-BACTERIAL AGENTS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; EUROPEAN UNION; HUMANS;

EID: 84980361845     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1080/14787210.2016.1216314     Document Type: Editorial

References (31)

1. B.M.Kagan, D.Krevsky, A.Milzer, et al. Polymyxin B and polymyxin E; clinical and laboratory studies. J Lab Clin Med. 1951;37(3):402–414.
2. D.Wong, B.Spellberg Leveraging antimicrobial stewardship into improving rates of carbapenem-resistant enterobacteriaceae. Virulence. 2016 May 17:1–8. [Epub ahead of print].
3. P.A.Bradford, K.M.Kazmierczak, D.J.Biedenbach, et al. Correlation of β-Lactamase production and colistin resistance among enterobacteriaceae isolates from a global surveillance program. Antimicrob Agents Chemother. 2015;60(3):1385–1392.
4. P.Garidel, K.Brandenburg. Current understanding of polymyxin B applications in bacteraemia/sepsis therapy prevention:clinical, pharmaceutical, structural and mechanistic aspects. Antiinfect Agents Med Chem. 2009;8(4):367–385.
5. D.L.Paterson, P.N.A.Harris. Colistin resistance:a major breach in our last line of defense. Lancet Infect Dis. 2016;16(2):132–133.
6. -Y.-Y.Liu, Y.Wang, T.R.Walsh, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China:a microbiological and molecular biology study. Lancet Infect Dis. 2016;16(2):161–168.• First report of the mcr-1 gene.
7. H.O.Khalifa, A.M.Ahmed, A.F.Oreiby, et al. Characterisation of the plasmid-mediated colistin resistance gene mcr-1 in Escherichia coli isolated from animals in Egypt. Int J Antimicrob Agents. 2016;47(5):413–414.
8. A.Quesada, M.Ugarte-Ruiz, M.R.Iglesias, et al. Detection of plasmid mediated colistin resistance (MCR-1) in Escherichia coli and Salmonella enterica isolated from poultry and swine in Spain. Res Vet Sci. 2016;105:134–135.
9. M.Doumith, G.Godbole, P.Ashton, et al. Detection of the plasmid-mediated mcr-1 gene conferring colistin resistance in human and food isolates of Salmonella enterica and Escherichia coli in England and Wales. J Antimicrob Chemother. 2016 Apr 18;71:2300–2305. pii:dkw093. [Epub ahead of print].
10. H.Hasman, A.M.Hammerum, F.Hansen, et al. Detection of mcr-1 encoding plasmid-mediated colistin-resistant Escherichia coli isolates from human bloodstream infection and imported chicken meat, Denmark 2015. Euro Surveill. 2015;20(49).
11. P.McGann, E.Snesrud, R.Maybank, et al. Escherichia coli harboring mcr-1 and blaCTX-M on a Novel IncF Plasmid:First report of mcr-1 in the USA. Antimicrob Agents Chemother. 2016. doi:10.1128/AAC.01103-16.
12. Z.Shen, Y.Wang, Y.Shen, et al. Early emergence of mcr-1 in Escherichia coli from food-producing animals. Lancet Infect Dis. 2016;16(3):293.
13. B.B.Xavier, C.Lammens, R.Ruhal, et al. Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. Euro Surveill. 2016;21(27):pii=30280.• First report of mcr-2 gene
14. M.Källberg, H.Wang, S.Wang, et al. Template-based protein structure modeling using the RaptorX web server. Nat Protoc. 2012;7(8):1511–1522.
15. S.-E.Cheah, M.D.Johnson, Y.Zhu, et al. Polymyxin resistance in acinetobacter baumannii:genetic mutations and transcriptomic changes in response to clinically relevant dosage regimens. Sci Rep. 2016 May 19;6:26233.
16. A.Beceiro, A.Moreno, N.Fernández, et al. Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii. Antimicrob Agents Chemother. 2014;58(1):518–526.
17. R.R.Watkins, R.A.Bonomo. Overview:global and local impact of antibiotic resistance. Infect Dis Clin North Am. 2016;30(2):313–322.
18. A.Hollis, Z.Ahmed. Preserving antibiotics, rationally. N Engl J Med. 2013;369(26):2474–2476.
19. B.Catry, M.Cavaleri, K.Baptiste, et al. Use of colistin-containing products within the European Union and European Economic Area (EU/EEA):development of resistance in animals and possible impact on human and animal health. Int J Antimicrob Agents. 2015;46(3):297–306.
20. P.Richez, D.G.S.Burch. Colistin in animals:a high risk for resistance selection in Europe? Vet Rec. 2016;178(4):101–102.
21. E.Sabuncu, J.David, C.Bernede-Bauduin, et al. Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002–2007. PLoS Med. 2009;6:e1000084.
22. C.Zhi, L.Huchao, Y.Lin-Feng, et al. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis. 2016;16(3):292–293.
23. The review on antimicrobial resistance. Final report. [cited 2016 Jun 12]. Available from: http://amr-review.org/Publications.•• Thorough report that details important ways to tackle AR.
24. S.Suzuki, M.Ohnishi, M.Kawanishi, et al. Investigation of a plasmid genome database for colistin-resistance gene mcr-1. Lancet Infect Dis. 2016;16(3):284–285.
25. L.B.Price, L.G.Lackey, R.Vailes. The persistence of fluoroquinolone-resistant Campylobacter in poultry production. Environ Health Perspect. 2007;115:1035–1039.
26. R.Nannapaneni, I.Hanning, K.C.Wiggins, et al. Ciprofloxacin-resistant Campylobacter persists in raw retail chicken after the fluoroquinolone ban. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2009;26(10):1348–1353.
27. I.Phillips. Withdrawal of growth-promoting antibiotics in Europe and its effects in relation to human health. Int J Antimicrob Agents. 2007;30(2):101–107.
28. Q.Chang, W.Wang, G.Regev-Yochay, et al. Antibiotics in agriculture and the risk to human health:how worried should we be? Evol Appl. 2015;8(3):240–247.
29. G.Stokka, T.J.Goldsmith. Feedlot vaccination:does it really matter? Vet Clin North Am Food Anim Pract. 2015;31(2):185–196.
30. G.Luo, L.Lin, A.S.Ibrahim, et al. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection. PLoS One. 2012;7(1):e29446.
31. R.L.Nation, J.Li, O.Cars, et al. Framework for optimisation of the clinical use of colistin and polymyxin B:the Prato polymyxin consensus. Lancet Infect Dis. 2015;15(2):225–234.